Lv41
490 积分 2021-04-15 加入
Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus
2小时前
待确认
Unilateral Secondary Facial Cleft with Excess Tooth and Bone Formation
2小时前
已完结
Epstein-Barr Virus Antibody Response Patterns in Endemic and Non-Endemic Cases of Nasopharyngeal Carcinoma
10天前
已完结
Nasopharyngeal carcinoma
15天前
已完结
Two Epstein-Barr Virus-Related Serologic Antibody Tests in Nasopharyngeal Carcinoma Screening: Results From the Initial Phase of a Cluster Randomized Controlled Trial in Southern China
2个月前
已关闭
Two Epstein-Barr Virus-Related Serologic Antibody Tests in Nasopharyngeal Carcinoma Screening: Results From the Initial Phase of a Cluster Randomized Controlled Trial in Southern China
2个月前
已完结
Toripalimab Combination Therapy Without Concurrent Cisplatin for Nasopharyngeal Carcinoma
2个月前
已完结
Evaluation of serum Epstein–Barr virus envelope glycoproteins antibodies and their association with systemic autoimmune diseases
3个月前
已完结
Adjuvant PD-1 Blockade With Camrelizumab for Nasopharyngeal Carcinoma
3个月前
已完结
Neoadjuvant and adjuvant toripalimab for locoregionally advanced nasopharyngeal carcinoma: a randomised, single-centre, double-blind, placebo-controlled, phase 2 trial
3个月前
已完结
皖公网安备34019202002308
